News

Most neuroscientific studies rely on a single experiment and assume their findings to be reliable. However, the validity of this assumption needs to be tested before accepting the findings as the ground truth.

A new analysis supports the hypothesis that viruses are living entities that share a long evolutionary history with cells, researchers report.

Latest competition offers £100,000 Phase 1 funding to companies developing healthcare innovations.

Thirteen grants awarded to look at cognitive and social development in approximately 10,000 children.

Bruker announced that its NMR FoodScreener™ laboratory for food authenticity and quality determination, located in Rheinstetten, Germany, has been granted ISO/IEC 17025 accreditation.

The acquisition will further strengthen and expand Aduro's immunotherapy capabilities to now encompass monoclonal antibodies, including preclinical assets that inhibit clinically validated immune checkpoint pathways.

CRISPR-Cpf1 system could disrupt both scientific and commercial landscape.

Simon Anthony studies animal infections to prevent outbreaks in people.

New screening tool produces up to 10,000-fold improvement in viral matches compared with traditional high-throughput methods.

Founded in 2015 after six years of work as part of the Enteroendocrine Discovery Performance Unit of GlaxoSmithKline, Phoundry Pharmaceuticals has created a portfolio of optimized peptides in various therapeutic categories, most notably diabetes and obesity.